0M61 Analyst Estimates: Price Targets, Revenue, Net Income, and EBIT Forecast - Myomo Inc - Alpha Spread

Myomo Inc
F:0M61

Watchlist Manager
Myomo Inc Logo
Myomo Inc
F:0M61
Watchlist
Price: 3.375 EUR -3.02% Market Closed
Market Cap: 71.2m EUR
Have any thoughts about
Myomo Inc?
Write Note

Wall Street
Price Targets

0M61 Price Targets Summary
Myomo Inc

Wall Street analysts forecast 0M61 stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for 0M61 is 5.686 EUR with a low forecast of 1.993 EUR and a high forecast of 7.826 EUR.

Lowest
Price Target
1.993 EUR
41% Downside
Average
Price Target
5.686 EUR
68% Upside
Highest
Price Target
7.826 EUR
132% Upside
Myomo Inc Competitors:
Price Targets
EKTA B
Elekta AB (publ)
13% Upside
IMR
Imricor Medical Systems Inc
83% Upside
4106
Wellell Inc
59% Upside
OPS
Opsens Inc
16% Upside
CEVI
CellaVision AB
4% Downside
ZOM
Zomedica Corp
238% Upside
BFLY
Butterfly Network Inc
59% Upside
CTSO
Cytosorbents Corp
223% Upside

Revenue
Forecast

Revenue Estimate
Myomo Inc

For the last 8 years the compound annual growth rate for Myomo Inc's revenue is 52%. The projected CAGR for the next 3 years is 37%.

52%
Past Growth
37%
Estimated Growth
Estimates Accuracy
5%
Average Beat

Operating Income
Forecast

Operating Income Estimate
Myomo Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-5%
Average Miss

Net Income
Forecast

Net Income Estimate
Myomo Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-89%
Average Miss

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is 0M61's stock price target?
Price Target
5.686 EUR

According to Wall Street analysts, the average 1-year price target for 0M61 is 5.686 EUR with a low forecast of 1.993 EUR and a high forecast of 7.826 EUR.

What is Myomo Inc's Revenue forecast?
Projected CAGR
37%

For the last 8 years the compound annual growth rate for Myomo Inc's revenue is 52%. The projected CAGR for the next 3 years is 37%.

Back to Top